this paper summarizes the proceedings of a 1 day national symposium entitled “reproductive biology, stem cells biotechnology and regenerative medicine” held at shahid sadoughi university of medical sciences, yazd, iran on 3rd march 2016. here, we collected the papers that presented and discussed at this meeting by specialists that currently researched about the overlaps of the fields of reprodu...

Nanotechnology has opened a new field in medicine as well as in other sciences. The aim of this study was to seek the capability of nanotechnology for the treatment of various reproductive diseases. In this study, we analyzed all articles about “nanotechnology and reproductive medicine” published in 2000-2015, indexed in Google Scholar, PubMed and Science Direct. This study indicated that nanot...

Adverse drug reactions (ADRs) are a major problem in drug therapy and drug development. Inter-individual genetic differences can have significant roles in determining an individual’s susceptibility to ADRs. The rapid development of techniques in the area of genome analysis has put the scientific community in a power position and facilitated identification of new pharmacogenomic biomarkers that ...

Natalie Z. Burger, M.D., Y. Elizabeth Hung, M.D., M.P.H., Alexandra N. Kalof, M.D., and Peter R. Casson, M.D. a Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Vermont, Burlington, Vermont; b Department of Obstetrics and Gynecology, North Shore University Hospital, Manhasset, New York; and c Department of Pathology, University of Ve...

Madam I look forward to the arrival of the Journal. It is always a good read, full of relevant and practical information – much more ‘user-friendly’ than most journals I receive these days. July’s edition seemed particularly interesting with a number of interesting articles. However, my interest was quickly replaced by irritation. There is a lot to be said for evidencebased medicine (EBM) and i...

This article surveys relevant moral and ethical implications of reproductive medicine, excluding any aspects of contraception. To maintain the methodological priority of a moral perspective, it focuses on moral theory and ethics in general before looking at the impact of ethics on the different techniques applied in reproductive medicine. We suggest that discourse ethics should be centre-stage ...

The development of biomarkers of reproductive medicine is still in its infancy because many black boxes are still present in reproductive medicine. Novel approaches to human infertility diagnostics and treatment must be developed because reproductive medicine has lagged behind in the implementation of biomarkers in clinical medicine. Despite the dearth of the available literature, the current r...